 | Up a level |
Behringer, K; Thielen, I; Mueller, H; Goergen, H; Eibl, A D; Rosenbrock, J; Halbsguth, T; Eichenauer, D A; Fuchs, M; Reiners, K S; Renno, J H; van der Ven, K; Kuehr, M; von Wolff, M.; Diehl, V; Engert, A; Borchmann, P (2020). Corrigendum to "Fertility and gonadal function in female survivors after treatment of early unfavorable Hodgkin lymphoma (HL) within the German Hodgkin Study Group HD14 trial": Annals of Oncology 2012; 23: 1818-1825. Annals of oncology, 31(8), p. 1093. Elsevier 10.1016/j.annonc.2020.05.020
Liebenthron, J; Reinsberg, J; van der Ven, K; Saenger, N; Kruessel, J-S; von Wolff, Michael (2020). Serum anti-Müllerian hormone concentration and follicle density throughout reproductive life and in different diseases-implications in fertility preservation. Human reproduction, 35(4), pp. 1009-1010. Oxford University Press 10.1093/humrep/deaa058
Liebenthron, J; Reinsberg, J; van der Ven, K; Saenger, N; Kruessel, J-S; von Wolff, M (2019). Serum anti-Müllerian hormone concentration and follicle density throughout reproductive life and in different diseases-implications in fertility preservation. Human reproduction, 34(12), pp. 2513-2522. Oxford University Press 10.1093/humrep/dez215
Behringer, K; Thielen, I; Mueller, H; Goergen, H; Eibl, A D; Rosenbrock, J; Halbsguth, T; Eichenauer, D A; Fuchs, M; Reiners, K S; Renno, J H; van der Ven, K; Kuehr, M; von Wolff, M; Diehl, V; Engert, A; Borchmann, P (2012). Fertility and gonadal function in female survivors after treatment of early unfavorable Hodgkin lymphoma (HL) within the German Hodgkin Study Group HD14 trial. Annals of oncology, 23(7), pp. 1818-25. Oxford: Oxford University Press 10.1093/annonc/mdr575
